Sun, Dec 21, 2014, 10:38 AM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Takeda Pharmaceutical Company Limited Message Board

  • brianpitt brianpitt Aug 7, 2013 6:05 AM Flag


    Takeda Submits Biologics License Application for a New Investigational Drug Vedolizumab, in Moderately to Severely Active Crohn's Disease and Ulcerative Colitis in the United States.

    Huge market for this drug in IBD and potentially in liver and bowel transplantation. Annual sales could blow past 1 billion. IMO Takeda has a strong pipeline and is cheap cheap cheap.

    Sentiment: Strong Buy

20.965+0.085(+0.41%)Dec 19 3:59 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.